期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Conservative management of perforated duodenal diverticulum: A case report and review of the literature 被引量:2
1
作者 David Martínez-Cecilia Alvaro Arjona Sánchez +7 位作者 Manuel Gómez álvarez Eva Torres Tordera Antonio Luque Molina Victor Valentí Azcárate Javier Briceo Delgado Francisco Javier Padillo Pedro López-Cillero Sebastián Rufián Pea 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第12期1949-1951,共3页
Duodenal diverticula are a relatively common condition. They are asymptomatic, unless they become complicated, with perforation being the rarest but most severe complication. Surgical treatment is the most frequently ... Duodenal diverticula are a relatively common condition. They are asymptomatic, unless they become complicated, with perforation being the rarest but most severe complication. Surgical treatment is the most frequently performed approach. We report the case of a patient with a perforated duodenal diverticulum, which was diagnosed early and treated conservatively with antibiotics and percutaneous drainage of secondary retroperitoneal abscesses. We suggest this method could be an acceptable option for the management of similar cases, provided that the patient is in good general condition and without septic signs. 展开更多
关键词 十二指肠 憩室 穿孔 保守治疗
下载PDF
Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations
2
作者 Diego Muñoz-Guglielmetti David Sanchez-Lorente +15 位作者 Roxana Reyes Daniel Martinez Carmen Lucena Marc Boada Pilar Paredes Marta Parera-Roig Ivan Vollmer Joel Mases Roberto Martin-Deleon Sergi Castillo Mariana Benegas Silvia Muñoz Maria Mayoral Carla Cases Meritxell Mollà Francesc Casas 《World Journal of Clinical Oncology》 CAS 2021年第11期1047-1063,共17页
BACKGROUND Neoadjuvant treatment(NT)with chemotherapy(Ch)is a standard option for resectable stage III(N2)NSCLC.Several studies have suggested benefits with the addition of radiotherapy(RT)to NT Ch.The International A... BACKGROUND Neoadjuvant treatment(NT)with chemotherapy(Ch)is a standard option for resectable stage III(N2)NSCLC.Several studies have suggested benefits with the addition of radiotherapy(RT)to NT Ch.The International Association for the Study of Lung Cancer(IASLC)published recommendations for the pathological response(PHR)of NSCLC resection specimens after NT.AIM To contribute to the IASLC recommendations showing our results of PHR to NT Ch vs NT chemoradiotherapy(ChRT).METHODS We analyzed 67 consecutive patients with resectable stage III NSCLC with positive mediastinal nodes treated with surgery after NT Ch or NT ChRT between 2013 and 2020.After NT,all patients were evaluated for radiological response(RR)according to Response Evaluation Criteria in Solid Tumours criteria and evaluated for surgery by a specialized group of thoracic surgeons.All histological samples were examined by the same two pathologists.PHR was evaluated by the percentage of viable cells in the tumor and the resected lymph nodes.RESULTS Forty patients underwent NT ChRT and 27 NT Ch.Fifty-six(83.6%)patients underwent surgery(35 ChRT and 21 Ch).The median time from ChRT to surgery was 6 wk(3-19)and 8 wk(3-21)for Ch patients.We observed significant differences in RR,with disease progression in 2.5%and 14.8%of patients with ChRT and Ch,respectively,and partial response in 62.5%ChRT vs 29.6%Ch(P=0.025).In PHR we observed≤10%viable cells in the tumor in 19(54.4%)and 2 cases(9.5%),and in the resected lymph nodes(RLN)30(85.7%)and 7(33.3%)in ChRT and Ch,respectively(P=0.001).Downstaging was greater in the ChRT compared to the Ch group(80%vs 33.3%;P=0.002).In the univariate analysis,NT ChRT had a significant impact on partial RR[odds ratio(OR)12.5;95%confidence interval(CI):1.21-128.61;P=0.034],a decreased risk of persistence of cancer cells in the tumor and RLN and an 87.5%increased probability for achieving downstaging(OR 8;95%CI:2.34-27.32;P=0.001).CONCLUSION We found significant benefits in RR and PHR by adding RT to Ch as NT.A longer follow-up is necessary to assess the impact on clinical outcomes. 展开更多
关键词 Non-small cell lung cancer CHEMOTHERAPY CHEMORADIOTHERAPY Neoadjuvant treatment Resectable stage III Pathological response
下载PDF
HLA B27 as Predisposition Factor to Suffer Age Related Macular Degeneration 被引量:2
3
作者 Enrique Villegas Becerril Rafael Gonzalez Fernandez +2 位作者 Luis Perula Torres Manuel Santos Lacomba Jose Maria Gallardo Galera 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2009年第4期303-307,共5页
To research whether specific alleles HLA class Ⅰ (HLA-A and HLA-B) and class Ⅱ (HLA-DR) are risk factors for the development of exudative type of Age Related Macular Degeneration(ARMD), HLA antigens are expres... To research whether specific alleles HLA class Ⅰ (HLA-A and HLA-B) and class Ⅱ (HLA-DR) are risk factors for the development of exudative type of Age Related Macular Degeneration(ARMD), HLA antigens are expressed both in normal and affected eyes with ARMD. We designed a prospective case-controlled study. We recruited 75 patients with choroidal neovascuiarization predominantly classic or occult, secondary to ARMD, and treated with photodynamic therapy. Two hundred and fifty patients over 55 years old, without ophthalmologic pathology who went to hospital for an analytical routine check were used as control. The analysis of the data shows a significant difference between two groups. Allele HLA-B27 correlated positively with ARMD (p 〈 0.0113). However, we didn't find alleles negatively associated. Thus HLA-B27 is an allele predisposed to suffer ARMD. 展开更多
关键词 HLA alleles ARMD HLA B27 patient with ARMD
原文传递
克罗恩病初次手术与多次手术患者的治疗及结局:基于PRACTICROHN研究数据
4
作者 Marisa Iborra Berta Juliá +7 位作者 Maria Dolores Martín Arranz Manuel Barreiro-de Acosta Ana Gutiérrez Valle García-Sánchez Carlos Taxonera Javier P.Gisbert Luis Cea-Calvo Eugeni Domènech 《Gastroenterology Report》 SCIE EI 2019年第6期411-418,I0001,I0002,共10页
背景:克罗恩病(CD)手术往往预后不佳,常需再次手术。本研究旨在比较初次手术与多次手术CD患者的术后治疗及临床结局。方法:本研究为观察性研究,纳入2007年1月至2010年12月间西班牙26家医院收治的行回结肠切除吻合术的成人CD患者。从医... 背景:克罗恩病(CD)手术往往预后不佳,常需再次手术。本研究旨在比较初次手术与多次手术CD患者的术后治疗及临床结局。方法:本研究为观察性研究,纳入2007年1月至2010年12月间西班牙26家医院收治的行回结肠切除吻合术的成人CD患者。从医疗记录中回顾性收集数据。结果:314例患者纳入分析,其中262例(83%)为初次手术病例,52例(17%)既往有过CD手术史。除狭窄型病变的患者比例再手术组相对较高以外(P=0.03),其余基线资料两组患者的差异均无统计学意义。术后接受预防性药物治疗的患者比例再手术组高于初次手术组(P=0.04)。再手术患者临床复发的时间与是否接受预防性药物治疗无关;但对于初次手术患者,接受预防性药物治疗者无复发生存时间更长(P=0.03)。结论:与初次手术者相比,既往有过CD手术史的患者术后更多接受了预防性药物(免疫调节剂)治疗。尽管预防性药物治疗可以预防初次手术者的临床复发,但并没有降低再次手术患者的复发风险。提示术后预防性药物治疗仍应仅限于初次手术患者。 展开更多
关键词 初次手术 观察性研究 医疗记录 克罗恩病 药物治疗者 狭窄型 基线资料 临床结局
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部